Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study.
Cancer Discov. 2022 Sep 2;12(9):2058-2073. doi: 10.1158/2159-8290.CD-21-1696.
Cancer Discov. 2022.
PMID: 35771551
Clinical Trial.
FGFR2 amplification in metastatic hormone-positive breast cancer and response to an mTOR inhibitor.
Wein L, Savas P, Van Geelen C, Caramia F, Moodie K, Joshi S, Loi S.
Wein L, et al.
Ann Oncol. 2017 Aug 1;28(8):2025-2027. doi: 10.1093/annonc/mdx194.
Ann Oncol. 2017.
PMID: 28430863
Free article.
No abstract available.
Item in Clipboard
Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
van Geelen CT, Savas P, Teo ZL, Luen SJ, Weng CF, Ko YA, Kuykhoven KS, Caramia F, Salgado R, Francis PA, Dawson SJ, Fox SB, Fellowes A, Loi S.
van Geelen CT, et al.
Breast Cancer Res. 2020 Aug 18;22(1):91. doi: 10.1186/s13058-020-01328-0.
Breast Cancer Res. 2020.
PMID: 32811538
Free PMC article.
Item in Clipboard
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
Zivanovic Bujak A, Weng CF, Silva MJ, Yeung M, Lo L, Ftouni S, Litchfield C, Ko YA, Kuykhoven K, Van Geelen C, Chandrashekar S, Dawson MA, Loi S, Wong SQ, Dawson SJ.
Zivanovic Bujak A, et al.
PLoS Med. 2020 Oct 1;17(10):e1003363. doi: 10.1371/journal.pmed.1003363. eCollection 2020 Oct.
PLoS Med. 2020.
PMID: 33001984
Free PMC article.
Item in Clipboard
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
van Geelen CT, Savas P, Teo ZL, Luen SJ, Weng CF, Ko YA, Kuykhoven KS, Caramia F, Salgado R, Francis PA, Dawson SJ, Fox SB, Fellowes A, Loi S.
van Geelen CT, et al.
Breast Cancer Res. 2022 Jul 15;24(1):50. doi: 10.1186/s13058-022-01539-7.
Breast Cancer Res. 2022.
PMID: 35841108
Free PMC article.
No abstract available.
Item in Clipboard
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme.
Thorne H, Devereux L, Li J, Alsop K, Christie L, van Geelen CT, Burdett N, Pishas KI, Woodford N, Leditschke J, Izzath MHMA, Strachan K, Young G, Jaravaza RD, Madadin MS, Archer M, Glengarry J, Iles L, Rathnaweera A, Hampson C, Almazrooei K, Burke M, Bandara P, Ranson D, Saeedi E, McNally O, Mileshkin L, Hamilton A, Ananda S, Au-Yeung G, Antill Y, Sandhu S, Savas P, Francis PA, Luen S, Loi S, Jennens R, Scott C, Moodie K, Cummings M, Reid A, McCart Reed A, Bowtell D, Lakhani SR, Fox S.
Thorne H, et al. Among authors: van geelen ct.
Histopathology. 2023 Jul;83(1):91-103. doi: 10.1111/his.14906. Epub 2023 Mar 31.
Histopathology. 2023.
PMID: 36999648
Item in Clipboard
Cite
Cite